Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...

(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The Nuvaxovid COVID-19 vaccine was developed in cooperation with Sanofi, which will pay Novavax $175 million in a milestone agreement. Novavax received Food and Drug Administration approval for its ...

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

A European Union court on Wednesday annulled a decision to withhold text messages exchanged between European Commission ...

Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and ...

A federal district judge is allowing the CIA to fire the agency’s director of the Center for Global Health Services ...